Search by First Name and/or Last Name. Results are displayed in descending publication year and then sorted ascending by the reference field. Need to submit a publication reference?
Name: David Holtzman
Year: 2013
Reference:
Perrin RJ, Payton JE, Malone JP, Gilmore P, Davis AE, Xiong C, Fagan AM, Townsend RR, Holtzman DM. Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.
PLoS One. 2013 May 20;8(5):e64314. doi: 10.1371/journal.pone.0064314. PMCID:PMC3659127
Name: catherine roe
Year: 2013
Reference:
Pizzie R, Hindman H, Roe CM, Head D, Grant E, Morris JC, Hassenstab JJ. Physical Activity and Cognitive Trajectories in Cognitively Normal Aduts: The Adult Children Study. Alzheimer’s Disease & Associated Disorders (In press).
Name: David Holtzman
Year: 2013
Reference:
Potter R, Patterson BW, Elbert DL, Ovod V, Kasten T, Sigurdson W, Mawuenyega K, Blazey T, Goate A, Chott R, Yarasheski KE, Holtzman DM, Morris JC, Benzinger TL, Bateman RJ.
Increased in Vivo Amyloid-β42 Production, Exchange, and Loss in Presenilin Mutation Carriers.
Sci Transl Med. 2013 Jun 12;5(189):189ra77. doi: 10.1126/scitranslmed.3005615.
Name: Alison Goate
Year: 2013
Reference:
Potter R, Patterson BW, Elbert DL, Ovod V, Kasten T, Sigurdson W, Mawuenyega K, Blazey T, Goate A, Chott R, Yarasheski KE, Holtzman DM, Morris JC, Benzinger TL, Bateman RJ. Increased in Vivo Amyloid-β42 Production, Exchange, and Loss in Presenilin Mutation Carriers. Sci Transl Med 2013; 5(189):189ra77. PMCID: PMC3838868
Name: Alison Goate
Year: 2013
Reference:
Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS, Valladares O, Lin CF, Larson EB, Graff-Radford NR, Evans D, De Jager PL, Crane PK, Buxbaum JD, Murrell JR, Raj T, Ertekin-Taner N, Logue M, Baldwin CT, Green RC, Barnes LL, Cantwell LB, Fallin MD, Go RC, Griffith P, Obisesan TO, Manly JJ, Lunetta KL, Kamboh MI, Lopez OL, Bennett DA, Hendrie H, Hall KS, Goate AM, Byrd GS, Kukull WA, Foroud TM, Haines JL, Farrer LA, Pericak-Vance MA, Schellenberg GD, Mayeux R; Alzheimer Disease Genetics Consortium. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013; 309(14):1483-92. PMCID:PMC3667653
Name: Alison Goate
Year: 2013
Reference:
Reitz C, Mayeux R; Alzheimer’s Disease Genetics Consortium. TREM2 and neurodegenerative disease. N Engl J Med. 2013; 369(16):1564-5. PMID: 24131184
Name: catherine roe
Year: 2013
Reference:
Roe CM, Behrens MI. AD and cancer: epidemiology makes for strange bedfellows. Neurology (in press).
Name: denise maue dreyfus
Year: 2013
Reference:
Roe CM, Fagan AM, Grant EA, Hassenstab J, Moulder KL, Maue Dreyfus D, Sutphen C, Benzinger TLS, Mintun MA, Holtzman DM, Morris JC. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later.
Neurology 2013. 10.1212/WNL.0b013e3182918ca6
Published online before print April 10, 2013
Name: Anne Fagan
Year: 2013
Reference:
Roe CM, Fagan AM, Grant EA, Hassenstab J, Moulder KL, Maue Dreyfus D, Sutphen CL, Benzinger TL, Mintun MA, Holtzman DM, Morris JC. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology. 2013 Apr 10. [Epub ahead of print] PMID: 23576620 [PubMed – as supplied by publisher]
Name: anne fagan
Year: 2013
Reference:
Roe CM, Fagan AM, Grant EA, Holtzman DM, Morris JC. CSF biomarkers of Alzheimer disease: “noncognitive” outcomes.Neurology. 2013 Dec 3;81(23):2028-31. doi: 10.1212/01.wnl.0000436940.78152.05. Epub 2013 Nov 8.
PMID:24212387
Name: catherine roe
Year: 2013
Reference:
Roe CM, Rentz DM. Alzheimer disease: before the diagnosis / About preclinical Alzheimer Disease. Neurology March 26, 2013 80:e148-e149.
Name: catherine roe
Year: 2013
Reference:
Shim YS, Roe CM, Buckles V, Morris JC. Clinicopathologic Study of Alzheimer’s Disease: Alzheimer mimics. Journal of Alzheimer’s Disease (In press).
Name: Anne Fagan
Year: 2013
Reference:
Stark SL, Roe CM, Grant EA, Hollingsworth H, Benzinger TL, Fagan AM, Buckles VD, Morris JC. Preclinical Alzheimer disease and risk of falls. Neurology. 2013 Jul 30;81(5):437-43. PMCID: PMC3776538
Name: catherine roe
Year: 2013
Reference:
Stark SL, Roe CM, Grant EA, Holly H, Benzinger TL, Fagan AM, Buckles VD, Morris JC. Preclinical Alzheimer’s disease and risk for falls. Neurology (In press).
Name: Anne Fagan
Year: 2013
Reference:
Sutphen CL, Fagan AM, Holtzman DM. Progress update: Fluid and imaging biomarkers in Alzheimer’s disease, Biological Psychiatry, in press
Name: david balota
Year: 2013
Reference:
Thomas AK, Lee M, Balota DA. Metacognitive monitoring and dementia: How intrinsic and extrinsic cues influence judgments of learning in people with early-stage Alzheimer’s disease. Neuropsychology 2013; 27: 452-463. PMCID: PMC4006849.
Name: David Holtzman
Year: 2013
Reference:
Ulrich JD, Burchett JM, Restivo JL, Schuler DR, Verghese PB, Mahan TE, Landreth GE, Castellano JM, Jiang H, Cirrito JR, Holtzman DM. In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis. Mol Neurodegener. 2013 Apr 19;8(1):13. PMCID: PMC3640999
Name: David Holtzman
Year: 2013
Reference:
Veeraraghavalu K, Zhang C, Miller S, Hefendehl JK, Rajapaksha TW, Ulrich J, Jucker M, Holtzman DM, Tanzi RE, Vassar R, Sisodia SS. Comment on “ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models”. Science. 2013 May 24;340(6135):924-f. doi: 10.1126/science.1235505.
Name: David Holtzman
Year: 2013
Reference:
Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C, Holtzman DM. ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions. Proc Natl Acad Sci U S A. 2013 2013 May 7:110(19):E1807-16. PMCID: PMC3651443
Name: David Holtzman
Year: 2013
Reference:
Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C, Holtzman DM. ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions. Proc Natl Acad Sci U S A. 2013 Apr 25. [Epub ahead of print]
PMID: 23620513
Name: Nigel Cairns
Year: 2013
Reference:
Vos SJ, Xiong C, Visser PJ, Jasielec MS, Hassenstab J, Grant EA, Cairns NJ, Morris JC, Holtzman DM, Fagan AM.Preclinical Alzheimer’s disease and its outcome: a longitudinal cohort study.Lancet Neurol. 2013 Oct;12(10):957-65. doi: 10.1016/S1474-4422(13)70194-7. Epub 2013 Sep 4.PMID:24012374
Name: Anne Fagan
Year: 2013
Reference:
Vos SJB, Xiong C, Visser PJ, Jasielec M, Hassenstab J, Grant EA, Cairns NJ, Morris JC, Holtzman DM, Fagan AM, Preclinical Alzheimer’s disease and its outcome: a longitudinal cohort study, Lancet Neurology, in press
Name: Anne Fagan
Year: 2013
Reference:
Wang L, Brier MR, Snyder AZ, Thomas JB, Fagan AM, Xiong C, Benzinger TL, Holtzman DM, Morris JC, Ances BM. Cerebrospinal Fluid Aβ42, Phosphorylated Tau181, and Resting-State Functional Connectivity. JAMA Neurol. 2013 Aug 19. doi: 10.1001/jamaneurol.2013.3253. [Epub ahead of print] PMID: 23959173 [PubMed – as supplied by publisher]
Name: Nigel Cairns
Year: 2013
Reference:
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Shen L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.The Alzheimer’s Disease Neuroimaging Initiative: a review of papers published since its inception.Alzheimers Dement. 2013 Sep;9(5):e111-94. doi: 10.1016/j.jalz.2013.05.1769. Epub 2013 Aug 7. PMID:23932184
Name: Anne Fagan
Year: 2013
Reference:
Winer L, Srinivasan D, Chun S, Lacomis D, Jaffa M, Fagan A, Holtzman DM, Wancewicz E, Bennett CF, Bowser R, Cudkowicz M, Miller TM. SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy. JAMA Neurol. 2013 Feb;70(2):201-7. Doi 10.1001/jamaneurol.2013.593. PMID: 23147550 [PubMed – indexed for MEDLINE]